澳洋健康(002172) - 2017 Q1 - 季度财报(更新)

Financial Performance - The company's operating revenue for Q1 2017 was ¥1,248,789,207.89, representing a 20.26% increase compared to ¥1,038,364,832.79 in the same period last year[9] - The net profit attributable to shareholders was ¥59,484,864.25, an increase of 80.02% from ¥33,043,336.99 year-on-year[9] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥53,719,547.43, up 89.18% from ¥28,396,100.39 in the previous year[9] - The basic earnings per share increased to ¥0.081, a rise of 68.75% from ¥0.048 in the same period last year[9] - Operating profit increased by 126.63% year-on-year, driven by growth in viscose gross profit[17] - Net profit increased by 118.20% year-on-year, attributed to growth in viscose profits and steady growth in the health industry[17] - The total profit increased by 114.26% year-on-year, driven by viscose profit growth and steady growth in the health industry[17] - Total operating revenue for the current period reached ¥1,234,084,789.95, a significant increase from ¥860,088,504.14 in the previous period, representing a growth of approximately 43.5%[48] - Net profit for the current period was ¥59,467,619.02, compared to ¥27,254,333.39 in the previous period, indicating an increase of about 118.5%[45] - Earnings per share (EPS) for the current period was ¥0.081, up from ¥0.048 in the previous period, reflecting a growth of 68.8%[45] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,590,220,247.35, reflecting an 11.34% increase from ¥4,122,526,891.08 at the end of the previous year[9] - Current liabilities totaled CNY 3,074,625,680.30, an increase from CNY 2,672,252,449.64, representing a rise of about 15.1%[32] - The total liabilities increased to CNY 3,186,304,824.67 from CNY 2,785,624,087.42, reflecting a growth of about 14.4%[32] - The company’s total equity reached CNY 1,403,915,422.68, compared to CNY 1,336,902,803.66, indicating an increase of approximately 5%[34] - The company’s long-term investments in equity reached CNY 1,161,617,547.91, up from CNY 1,141,336,281.54, indicating a growth of about 1.8%[34] Cash Flow - The net cash flow from operating activities was negative at -¥198,651,725.24, a decline of 378.90% compared to ¥71,226,244.75 in the same period last year[9] - The net cash flow from operating activities decreased by 378.90% year-on-year, mainly due to reduced inflows and increased expenditures[17] - Operating cash flow net amount was -191,067,704.68 yuan, compared to -61,476,786.79 yuan in the previous period, indicating a significant decline[57] - Cash inflow from operating activities totaled 607,410,337.90 yuan, down from 658,152,988.05 yuan in the previous period, indicating a decline in operational performance[57] - Cash outflow for purchasing goods and services was 780,234,014.36 yuan, compared to 712,378,739.33 yuan in the previous period, showing increased operational costs[57] - The company reported a cash flow impact from exchange rate changes of -51,865.01 yuan, indicating minor foreign exchange losses[59] - The net increase in cash and cash equivalents was -75,559,316.36 yuan, compared to -29,996,972.89 yuan in the previous period, highlighting ongoing cash flow challenges[59] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 46,004[13] - The company completed a capital increase of 17.44 million yuan from strategic investor Funi City Investment Development Co., Ltd., raising the registered capital to 69,773 million yuan[19] Government Support and Taxation - The company received government subsidies amounting to ¥12,791,130.93 during the reporting period[10] - The company received tax refunds that increased by 35.65% year-on-year, due to higher government tax refunds received during the period[17] - The company incurred tax expenses of ¥2,147,048.71, up from ¥1,502,242.92 in the previous period, which is an increase of approximately 43.1%[45] Operational Costs - Total operating costs increased to ¥1,199,617,325.16 from ¥1,016,667,526.39, which is an increase of about 17.9%[45] - The company reported a decrease in financial expenses to ¥11,551,331.57 from ¥14,980,513.90, a reduction of approximately 22.4%[45] - The company reported an increase in sales expenses to ¥38,395,131.57 from ¥32,495,588.94, reflecting a rise of about 18.5%[45] Audit and Reliability - The company did not conduct an audit for the first quarter report, which may affect the reliability of the financial data presented[60]